These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4121173)

  • 1. Biosynthetic properties of H-2 alloantigens: turnover rate in H-2 d tumor cells.
    Schwartz BD; Wickner S; Rajan TV; Nathenson SG
    Transplant Proc; 1973 Mar; 5(1):439-42. PubMed ID: 4121173
    [No Abstract]   [Full Text] [Related]  

  • 2. H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent.
    Schwartz BD; Kato K; Cullen SE; Nathenson SG
    Biochemistry; 1973 May; 12(11):2157-64. PubMed ID: 4196220
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective loss of H-2 antigenic reactivity after chemical modification.
    Pancake SJ; Nathenson SG
    J Immunol; 1973 Oct; 111(4):1086-92. PubMed ID: 4125608
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments.
    Cullen SE; Nathenson SG
    J Immunol; 1971 Aug; 107(2):563-70. PubMed ID: 4105541
    [No Abstract]   [Full Text] [Related]  

  • 6. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 7. Solubilization, properties and molecular separation of HL-A alloantigens.
    Mann DL; Rogentine GN; Fahey JL; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):494-7. PubMed ID: 4109224
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice.
    Greenberg AH; Playfair JH
    Clin Exp Immunol; 1974 Jan; 16(1):99-109. PubMed ID: 4143189
    [No Abstract]   [Full Text] [Related]  

  • 12. The isolation and characterization of soluble murine H-2 alloantigens.
    DiPadua D; McKenzie IF; Russell PS
    Transplant Proc; 1973 Mar; 5(1):435-8. PubMed ID: 4572105
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
    Bonavida B
    J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antigenic determinant of cytotoxic lymphocytes.
    Sullivan KA; Berke G; Amos DB
    Transplantation; 1973 Oct; 16(4):388-91. PubMed ID: 4126790
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical properties of papain-solubilized murine and human histocompatibility alloantigens.
    Nathenson SG; Shimada A; Yamane K; Muramatsu T; Cullen S; Mann DL; Fahey JL; Graff R
    Fed Proc; 1970; 29(6):2026-33. PubMed ID: 4098338
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxicity inhibition studies using 3 M KCl solubilized murine histocompatibility antigens and a new multiple automated sample harvester.
    Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM
    J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4765855
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxicity inhibition studies using 3 M KC1 solubilized murine histocompatibility antigens and a new multiple automated sample harvester.
    Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM
    J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4732342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.